Interestingly, high levels of the enzymes thioredoxin and thioredoxin reductase (which have previously been associated with disease severity) are found in the plasma of RA patients and maintain the reduced status of HMGB1, its ability to bind CXCL12 and therefore exert inflammatory activity. Here, CXCL12 is linked to rheumatoid arthritis.